BR112016021016A2 - - Google Patents
Info
- Publication number
- BR112016021016A2 BR112016021016A2 BR112016021016A BR112016021016A BR112016021016A2 BR 112016021016 A2 BR112016021016 A2 BR 112016021016A2 BR 112016021016 A BR112016021016 A BR 112016021016A BR 112016021016 A BR112016021016 A BR 112016021016A BR 112016021016 A2 BR112016021016 A2 BR 112016021016A2
- Authority
- BR
- Brazil
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14162587.1 | 2014-03-31 | ||
EP14162587.1A EP2927235B1 (en) | 2014-03-31 | 2014-03-31 | Polymorphic mixture of rifaximin and its use for the preparation of solid formulations |
PCT/EP2015/056304 WO2015150171A1 (en) | 2014-03-31 | 2015-03-24 | Polymorphic mixture of rifaximin and its use for the preparation of solid formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016021016A2 true BR112016021016A2 (pt-PT) | 2017-08-15 |
BR112016021016B1 BR112016021016B1 (pt) | 2022-06-21 |
Family
ID=50479018
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016021016-6A BR112016021016B1 (pt) | 2014-03-31 | 2015-03-24 | Mistura polimórfica de rifaximina, composição farmacêutica, comprimido e processo para a preparação da mesma |
BR122020022453-3A BR122020022453B1 (pt) | 2014-03-31 | 2015-03-24 | Utilização de misturas polimórficas de rifaximina na preparação de formulações sólidas e processo para a preparação de um comprimido revestido com película |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122020022453-3A BR122020022453B1 (pt) | 2014-03-31 | 2015-03-24 | Utilização de misturas polimórficas de rifaximina na preparação de formulações sólidas e processo para a preparação de um comprimido revestido com película |
Country Status (6)
Country | Link |
---|---|
US (6) | US10556915B2 (pt-PT) |
EP (2) | EP2927235B1 (pt-PT) |
JP (3) | JP2017509666A (pt-PT) |
BR (2) | BR112016021016B1 (pt-PT) |
ES (1) | ES2621557T3 (pt-PT) |
WO (1) | WO2015150171A1 (pt-PT) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1698630T1 (sl) | 2005-03-03 | 2015-01-30 | Alfa Wassermann S.P.A. | Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih |
ES2621557T3 (es) | 2014-03-31 | 2017-07-04 | Euticals S.P.A. | Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas |
PL3546464T3 (pl) | 2014-05-12 | 2020-11-02 | Alfasigma S.P.A. | Sposób wytwarzania i zastosowanie postaci krystalicznej Tau rifaksyminy solwatowanej z DEGME |
PL3434265T3 (pl) | 2016-03-24 | 2021-12-13 | Sandoz Ag | Kompozycja farmaceutyczna zawierająca rifaksyminę alfa i delta |
MX2018010065A (es) | 2017-04-26 | 2019-02-07 | Sandoz Ag | Forma de dosificacion oral que comprende rifaximina en forma beta. |
US10368752B1 (en) | 2018-03-08 | 2019-08-06 | Hi Llc | Devices and methods to convert conventional imagers into lock-in cameras |
US20220062183A1 (en) * | 2018-12-19 | 2022-03-03 | Friulchem S.P.A. | Process for the manufacture of a tablet of rifaximin and tablet of rifaximin |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
IT1199374B (it) | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
CA1215976A (en) | 1984-05-15 | 1986-12-30 | Vincenzo Cannata | New process for the synthesis of imidazo rifamycins |
IT1199413B (it) | 1984-09-26 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
IT1264494B1 (it) | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
IT1290679B1 (it) | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
US7902206B2 (en) | 2003-11-07 | 2011-03-08 | Alfa Wassermann, S.P.A. | Polymorphic forms α, β and γ of rifaximin |
ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
US7906542B2 (en) | 2004-11-04 | 2011-03-15 | Alfa Wassermann, S.P.A. | Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin |
US7923553B2 (en) | 2003-11-07 | 2011-04-12 | Alfa Wassermann, S.P.A. | Processes for the production of polymorphic forms of rifaximin |
SI1698630T1 (sl) | 2005-03-03 | 2015-01-30 | Alfa Wassermann S.P.A. | Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih |
ITMI20061692A1 (it) | 2006-09-05 | 2008-03-06 | Alfa Wassermann Spa | Uso di polioli per ottenere forme polimorfe stabili di rifaximina |
KR101667534B1 (ko) | 2006-09-22 | 2016-10-19 | 씨아이피엘에이 엘티디. | 리팍시민 |
ITMI20071241A1 (it) | 2007-06-20 | 2008-12-21 | Solmag S P A | Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta |
ES2389358T5 (es) * | 2007-07-06 | 2016-01-19 | Lupin Ltd. | Composiciones farmacéuticas de rifaximina |
US7709634B2 (en) | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
US8486956B2 (en) | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
BRPI0908864A2 (pt) | 2008-02-25 | 2018-09-18 | Salix Pharmaceuticals Ltd | formas da rifaximina e usos das mesmas |
PL2252148T3 (pl) | 2008-02-26 | 2019-09-30 | Salix Pharmaceuticals, Ltd. | Sposoby leczenia zespołu jelita drażliwego |
US20110035232A1 (en) | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
DK3628319T3 (da) | 2008-10-02 | 2024-03-04 | Salix Pharmaceuticals Ltd | Behandling af hepatisk encefalopati ved anvendelse af rifaximin |
US7928115B2 (en) | 2008-10-02 | 2011-04-19 | Salix Pharmaceuticals, Ltd. | Methods of treating travelers diarrhea and hepatic encephalopathy |
WO2011080691A1 (en) | 2009-12-28 | 2011-07-07 | Silvio Massimo Lavagna | Method for the production of amorphous rifaximin |
MX2012013945A (es) | 2010-06-03 | 2013-05-06 | Salix Pharmaceuticals Ltd | Nuevas formas de rifaximina y usos de las mismas. |
CA2802874A1 (en) | 2010-06-16 | 2011-12-22 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
US8759513B2 (en) | 2010-09-13 | 2014-06-24 | Sequent Scientific Limited | Polymorphic form of rifaximin and process for its preparation |
WO2012060675A1 (es) | 2010-11-05 | 2012-05-10 | Interquim, S.A. De C.V. | Proceso para la preparación de rifaximina amorfa |
EA201391171A1 (ru) | 2011-02-11 | 2014-11-28 | Сэликс Фармасьютиклз, Лтд. | Формы рифаксимина и их применение |
EP2705042A1 (en) | 2011-05-02 | 2014-03-12 | Ranbaxy Laboratories Limited | Rifaximin dimethylformamide solvate |
WO2012155981A1 (en) | 2011-05-19 | 2012-11-22 | Friulchem Spa | New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby |
ITMI20110890A1 (it) | 2011-05-19 | 2012-11-20 | A M S A Anonima Materie Sint & Affini S P A | Polimorfo di rifaximina e processo per la sua preparazione |
WO2013027227A1 (en) | 2011-07-20 | 2013-02-28 | Ind-Swift Laboratories Limited | Novel polymorphic form i of rifaximin |
JP2013184902A (ja) | 2012-03-06 | 2013-09-19 | Aska Pharmaceutical Co Ltd | リファキシミン含有結晶 |
CA2876737A1 (en) | 2012-06-13 | 2013-12-19 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
WO2014091432A1 (en) | 2012-12-12 | 2014-06-19 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of rifaximin |
US9018225B1 (en) | 2013-07-26 | 2015-04-28 | Novel Laboratories | Rifaximin crystalline forms and methods of preparation thereof |
ITMI20131307A1 (it) | 2013-08-02 | 2015-02-02 | A M S A Anonima Materie Sint & Affini S P A | Processo per la preparazione di refaximina k |
ES2621557T3 (es) | 2014-03-31 | 2017-07-04 | Euticals S.P.A. | Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas |
US9765088B2 (en) | 2014-04-19 | 2017-09-19 | Granules India Limited | Process for the preparation of rifamycin derivatives |
PL3546464T3 (pl) | 2014-05-12 | 2020-11-02 | Alfasigma S.P.A. | Sposób wytwarzania i zastosowanie postaci krystalicznej Tau rifaksyminy solwatowanej z DEGME |
JP2022019164A (ja) | 2020-07-17 | 2022-01-27 | 京セラドキュメントソリューションズ株式会社 | 画像形成装置、トナー帯電量取得方法 |
-
2014
- 2014-03-31 ES ES14162587.1T patent/ES2621557T3/es active Active
- 2014-03-31 EP EP14162587.1A patent/EP2927235B1/en not_active Revoked
-
2015
- 2015-03-24 US US15/300,879 patent/US10556915B2/en active Active
- 2015-03-24 EP EP15711554.4A patent/EP3126367A1/en not_active Withdrawn
- 2015-03-24 BR BR112016021016-6A patent/BR112016021016B1/pt active IP Right Grant
- 2015-03-24 WO PCT/EP2015/056304 patent/WO2015150171A1/en active Application Filing
- 2015-03-24 BR BR122020022453-3A patent/BR122020022453B1/pt active IP Right Grant
- 2015-03-24 JP JP2016559987A patent/JP2017509666A/ja not_active Withdrawn
-
2019
- 2019-09-11 US US16/567,852 patent/US10745415B2/en active Active
- 2019-09-12 US US16/569,275 patent/US10961257B2/en active Active
- 2019-11-25 JP JP2019212153A patent/JP2020073486A/ja active Pending
-
2021
- 2021-01-26 US US17/158,843 patent/US11739099B2/en active Active
- 2021-10-29 US US17/513,966 patent/US20220048926A1/en active Pending
-
2022
- 2022-02-10 JP JP2022019164A patent/JP2022070944A/ja active Pending
-
2023
- 2023-03-29 US US18/127,839 patent/US20230234966A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2017509666A (ja) | 2017-04-06 |
ES2621557T3 (es) | 2017-07-04 |
EP3126367A1 (en) | 2017-02-08 |
US20220041622A9 (en) | 2022-02-10 |
US20230234966A1 (en) | 2023-07-27 |
US10556915B2 (en) | 2020-02-11 |
JP2022070944A (ja) | 2022-05-13 |
EP2927235A1 (en) | 2015-10-07 |
US20200002356A1 (en) | 2020-01-02 |
US20200002357A1 (en) | 2020-01-02 |
US20170015682A1 (en) | 2017-01-19 |
US10745415B2 (en) | 2020-08-18 |
US10961257B2 (en) | 2021-03-30 |
BR122020022453B1 (pt) | 2023-02-23 |
BR112016021016B1 (pt) | 2022-06-21 |
US11739099B2 (en) | 2023-08-29 |
US20220048926A1 (en) | 2022-02-17 |
US20210147444A1 (en) | 2021-05-20 |
WO2015150171A1 (en) | 2015-10-08 |
EP2927235B1 (en) | 2017-02-08 |
JP2020073486A (ja) | 2020-05-14 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/03/2015, OBSERVADAS AS CONDICOES LEGAIS |